UPDATE: Luminex Gains FDA Clearance for Gastro Test; Expects Clearance for Newborn Test in H2 | GenomeWeb

This article has been updated from a version posted Jan. 10 to reflect the fact that Luminex has gained clearance for its gastrointestinal panel.

Luminex this week said that the US Food and Drug Administration has cleared its xTAG Gastrointestinal Pathogen Panel for marketing in the US.

The clearance follows comments made last week at the JP Morgan Healthcare conference in San Francisco by CEO Patrick Balthrop, who told investors that the company expected clearance within a month.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.